Bead-Based Immunoassay for Phosphorylated GPCR Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for determining GPCR phosphorylation are labor-intensive, time-consuming, and not suitable for high-throughput assays, limiting the ability to rapidly generate and characterize phosphosite-specific antibodies, which are essential for drug development and research.
Innovation Solution
A bead-based immunoassay for determining agonist-induced phosphorylation of GPCRs in a high-throughput manner, allowing for the quantitative measurement of phosphorylated receptors, temporal dynamics of phosphorylation, and identification of kinases and phosphatases involved, while enabling the generation of dose-response curves for agonists and antagonists.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If phosphosite-specific antibodies are generated through traditional mutation studies and radioactive phosphorylation assays, then specific phosphorylation sites can be identified, but the process requires very long periods (10 to 15 years) and is extremely time-consuming
Solution Approach 1:
The invention changes the detection parameter from radioactive labeling to fluorescent labeling, enabling high-throughput screening without the time-consuming mutation studies. The fluorescently labeled antibodies can directly detect phosphorylated receptors in a bead-based assay format, reducing the development time from 10-15 years to a much shorter period while maintaining detection accuracy.
Solution Approach 2:
The invention replaces the mechanical and labor-intensive process of mutation studies with a fluorescent-based detection system. The bead-based fluorescent assay allows for automated, high-throughput screening of phosphorylation sites without requiring individual mutation analysis, thus substituting a time-consuming manual process with a more efficient automated system.
2Productivity
If high throughput assays are implemented for drug screening, then thousands of substances can be tested in short time, but current phosphorylation determination methods are NOT available for high throughput applications
Solution Approach 1:
The invention creates a universal fluorescent-based phosphorylation detection system that can be applied to multiple GPCR targets simultaneously in a high-throughput format. The bead-based assay platform can screen thousands of compounds across multiple phosphorylation sites in parallel, making the method adaptable to various drug screening applications while maintaining the ability to detect phosphorylation events.
3Reliability
If whole-cell radioactive phosphorylation studies are used to detect phosphorylation, then phosphorylation can be detected, but the method is laborious and does not provide information on individual serine and threonine sites
Solution Approach 1:
The invention applies local quality by using site-specific fluorescent antibodies that target individual phosphorylation sites on GPCRs. Each antibody is designed to recognize a specific serine or threonine residue, allowing the detection of phosphorylation at particular locations while maintaining the reliability of overall phosphorylation detection. This enables both quantitative and qualitative information to be obtained simultaneously.
4Manufacturing precision
If phosphosite-specific antibodies are generated for individual GPCRs, then excellent tools for detecting receptor activation are available, but this work has only been successful for about 10 out of 400 GPCRs
Solution Approach 1:
The invention segments the GPCR family into individual targets that can be analyzed separately using the fluorescent bead-based assay. This segmentation allows researchers to systematically generate phosphosite-specific antibodies for each GPCR without being overwhelmed by the complexity of the entire family, thereby increasing the number of GPCRs (from 10 to potentially all 400) for which specific antibodies can be developed while maintaining high specificity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid and quantitative determination of GPCR phosphorylation, facilitating drug screening and characterization of novel drugs by providing a high-throughput method for generating and testing phosphosite-specific antibodies, thus accelerating the drug development process.
Implementation Method 1
A bead-based immunoassay for determining agonist-induced phosphorylation of GPCRs in a high-throughput manner, allowing for the quantitative measurement of phosphorylated receptors
Data Source
AI summary
The present invention relates to a collection of seven-transmembrane receptor (7TMR) specific antibodies. A further aspect of the invention relates to a method for determining a phosphorylation status of a 7TMR polypeptide.